SEC Form 4 · accession 0001354488-15-002610
Midatech Pharma US Inc. · DARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul John Richardson
Director
Period of report
May 19, 2015
Accepted (ET)
May 20, 2015 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000919745
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.69 | May 19, 2015 | A | 21,739 | A | — | May 19, 2025 | Common Stock | 21,739 | 21,739 | D |
Explanation of responses
- F1This option was granted on May 19, 2015 and vests on September 19, 2015.